The Medical Supply Chain Resiliency Act aims to bolster the United States' national security and public health by enhancing the resilience of its medical supply chains. It empowers the President to negotiate and enter into "trusted trade partner agreements" with countries willing to reciprocally eliminate duties and other import restrictions on medical goods. These agreements are intended to address vulnerabilities exposed during the COVID-19 pandemic, such as over-reliance on a few import partners and global supply disruptions.

To qualify as a trusted trade partner, a country must demonstrate a commitment to global health security, maintain open trade during emergencies, adhere to existing trade agreements, and protect intellectual property rights. The agreements themselves can include provisions for reducing trade barriers, diversifying supplier networks, and harmonizing regulatory procedures to expedite the cross-border movement of medical goods. They also aim to increase access to government procurement markets and foster international collaboration in research, development, and manufacturing of medical products.

The bill establishes a robust congressional oversight process for these agreements. Before initiating negotiations, the President must provide notice to Congress and consult with relevant committees and federal agencies. Congress retains the right to review and potentially disapprove any proposed agreement through a structured review period and joint resolution process, ensuring legislative input and accountability.

Furthermore, the Act mandates ongoing monitoring and enforcement of these agreements. The Trade Representative will periodically assess a partner's compliance with its commitments. If a trusted trade partner fails to meet its obligations, the President is authorized to take various actions, including suspending or withdrawing the agreement, or negotiating compensatory trade benefits to protect U.S. interests. This framework seeks to create a more secure and reliable supply of essential medical goods for the United States.